Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03752983
Recruitment Status : Not yet recruiting
First Posted : November 26, 2018
Last Update Posted : January 29, 2019
Sponsor:
Information provided by (Responsible Party):
Mariam Khamis Mohamed, Assiut University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : March 1, 2020
Estimated Study Completion Date : December 1, 2020